1-[[2-(4-bromophenyl)-6-(1-methylpyrazol-4-yl)-3-pyridinyl]oxy]-2-methylpropan-1-ol
C19H20BrN3O2 — CID 90783304
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1-[[2-(4-bromophenyl)-6-(1-methylpyrazol-4-yl)-3-pyridinyl]oxy]-2-methylpropan-1-ol
1-[[2-(4-bromophenyl)-6-(1-methylpyrazol-4-yl)-3-pyridinyl]oxy]-2-methylpropan-1-ol (PubChem CID 90783304) has the molecular formula C19H20BrN3O2 and a molecular weight of 402.29 g/mol. Its IUPAC name is 1-[[2-(4-bromophenyl)-6-(1-methylpyrazol-4-yl)-3-pyridinyl]oxy]-2-methylpropan-1-ol.
Molecular Properties
| Compound Name | 1-[[2-(4-bromophenyl)-6-(1-methylpyrazol-4-yl)-3-pyridinyl]oxy]-2-methylpropan-1-ol |
|---|---|
| PubChem CID | 90783304 |
| Molecular Formula | C19H20BrN3O2 |
| Molecular Weight | 402.29 g/mol |
| Exact Mass | 401.07 |
| IUPAC Name | 1-[[2-(4-bromophenyl)-6-(1-methylpyrazol-4-yl)-3-pyridinyl]oxy]-2-methylpropan-1-ol |
| SMILES | CC(C)C(O)Oc1ccc(-c2cnn(C)c2)nc1-c1ccc(Br)cc1 |
| InChI | InChI=1S/C19H20BrN3O2/c1-12(2)19(24)25-17-9-8-16(14-10-21-23(3)11-14)22-18(17)13-4-6-15(20)7-5-13/h4-12,19,24H,1-3H3 |
| InChIKey | TWEHPFNVKOGOPX-UHFFFAOYSA-N |
| XLogP | 4.26 |
| TPSA | 60.17 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.29 |
| LogP ≤ 5 | 4.26 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'het-C-het_not_in_ring', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 90783304 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.